Efficacy of a cannabis-based oromucosal spray in managing pain of rheumatoid arthritis
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritisRheumatology (Oxford, England). 2006;(1):Feb-50.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
58 patients diagnosed with rheumatoid arthritis (RA) were randomized to either Sativex or placebo. Patients were assessed over 5 weeks of treatment. Significant improvements in pain and quality of sleep were found in patients that received Sativex compared to those that received placebo. No effect was found on morning stiffness. No patients in Sativex group versus two patients in the placebo group...
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.Continue